| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BICYCLE THERAPEUTICS plc | Director | Ordinary Shares | 12K | $210K | $17.50 | Feb 20, 2024 | Direct |
| Cyteir Therapeutics, Inc. | Director | Common Stock | 12.1K | $20.5K | $1.69 | Feb 9, 2024 | Direct |
| BICYCLE THERAPEUTICS plc | Director | Stock Option (right to buy) | 24K | Feb 20, 2024 | Direct | ||
| Cyteir Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | Feb 9, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BCYC | BICYCLE THERAPEUTICS plc | Feb 20, 2024 | 2 | $0 | 4 | Feb 21, 2024 | Director |
| BCYC | BICYCLE THERAPEUTICS plc | Feb 20, 2024 | 0 | $0 | 3 | Feb 21, 2024 | Director |
| CYT | Cyteir Therapeutics, Inc. | Feb 9, 2024 | 2 | $20.5K | 4 | Feb 14, 2024 | Director |
| CYT | Cyteir Therapeutics, Inc. | Feb 3, 2023 | 1 | $0 | 4 | Feb 7, 2023 | Director |
| CYT | Cyteir Therapeutics, Inc. | Feb 22, 2022 | 1 | $0 | 4 | Feb 24, 2022 | Director |
| CYT | Cyteir Therapeutics, Inc. | Feb 22, 2022 | 0 | $0 | 3 | Feb 24, 2022 | Director |